Xtx Topco LTD Agios Pharmaceuticals, Inc. Transaction History
Xtx Topco LTD
- $1.3 Billion
- Q3 2024
A detailed history of Xtx Topco LTD transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 8,329 shares of AGIO stock, worth $324,997. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,329
Previous 5,333
56.18%
Holding current value
$324,997
Previous $229,000
61.57%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$221 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$216 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$190 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$146 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$111 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.14B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...